President Uhuru Kenyatta today in State House, Nairobi witnessed the signing of a memorandum of understanding between Kenya and Moderna to establish the first mRNA manufacturing facility in Africa. The state-of-the-art mRNA facility in Africa is expected to produce up to 500 million doses of vaccines each year. The Company anticipates investing up to $500 million in the new facility, which will focus on drug substance manufacturing on the continent of Africa for the continent of Africa. President Kenyatta has been in fore front championing for the African continent to manufacture its own COVID…

Read More